Major european hunt for clues to stop dangerous virus in transplant patients
NCT ID NCT05701228
Summary
This study aims to understand why some organ transplant patients develop severe, hard-to-treat Cytomegalovirus (CMV) infections. Researchers are collecting blood samples and health data from over 550 transplant patients across Europe. By studying these samples, they hope to identify which patients are most at risk and find better ways to prevent and manage this serious complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopitel Pellegrin
Bordeaux, 33076, France
-
Hôpital Edouard Hériot
Lyon, 69003, France
-
Hôpital Foch
Suresnes, 92150, France
-
Hôpital LA PITIE SALPETRIERE
Paris, 75013, France
-
Hôpital Necker
Paris, 75015, France
-
Hôpital Paul Brousse
Villejuif, 94804, France
-
Hôpital Rangueil
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.